Sort by
Keyphrases
Abstract Presentation
14%
American Society of Hematology
14%
Anticoagulation
14%
Apixaban
14%
Atrial Fibrillation
28%
Clinical Experience
14%
Clinical Observation
14%
Clinical Practice
14%
Clinical Trials
14%
Common Side Effects
14%
Dizziness
71%
Edoxaban
14%
Factor Xa Inhibitors
28%
Florida
14%
Headache
71%
Hypotensive Effect
100%
King's College London
14%
Male Population
14%
Novel Oral Anticoagulants
100%
Older Adult Population
14%
Oral Anticoagulant Drugs
100%
Oral Anticoagulant Therapy
14%
Paroxysmal Atrial Fibrillation
14%
Patient Reporting
14%
Pharmacological Activities
14%
Project-led
14%
Reported Incidence
14%
Rivaroxaban
100%
Standard of Care
14%
Stroke Prevention
14%
Stroke Prophylaxis
14%
Stroke Risk
14%
Systemic Embolism
28%
Therapy Discontinuation
14%
Treatment Discontinuation
14%
Vascular Relaxation
14%
Venous Stroke
14%
Venous Thromboembolism Prophylaxis
14%
Ventricular Arrhythmia
14%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Anticoagulation Therapy
14%
Apixaban
14%
Atrial Fibrillation
42%
Cerebrovascular Accident
42%
Clinical Trial
14%
Dizziness
71%
Edoxaban
14%
Embolism
28%
Headache
71%
Heart Arrhythmia
14%
Pharmacological Activity
14%
Prevalence
14%
Rivaroxaban
100%
Side Effect
14%
Venous Thromboembolism
14%